Abstract
Ultraviolet (UV) wavelengths in sunlight are the prime cause of skin cancer in humans with both the UVA and UVB wavebands making a contribution to photocarcinogenesis. UV has many different biological effects on the skin that contribute to carcinogenesis, including suppression of adaptive immunity, sunburn and altering the migration of mast cells into and away from irradiated skin. Many molecular mechanisms have been identified as contributing to skin responses to UV. Recently, using gene set enrichment analysis of microarray data, we identified the alternative complement pathway with a central role for factor B (fB) in UVA-induced immunosuppression. In the current study we used mice genetically deficient in fB (fB−/− mice) to study the functional role of the alternative complement pathway in skin responses to UV. We found that fB is required for not only UVA but also UVB-induced immunosuppression and solar-simulated UV induction of the oedemal component of sunburn. Factor B−/− mice had a larger number of resident skin mast cells than control mice, but unlike the controls did not respond to UV by increasing mast cell infiltration into the skin. This study provides evidence for a function role for fB in skin responses to UV radiation. Factor B regulates UVA and UVB induced immunosuppression, UV induced oedema and mast cell infiltration into the skin. The alternative complement pathway is therefore an important regulator of skin responses to UV.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
G. M. Halliday, M. Norval, S. N. Byrne, X. X. Huang and P. Wolf, The effects of sunlight on the skin, Drug Discovery Today: Dis. Mech., 2008, 5, 201–209.
A. C. Chen, D. L. Damian and G. M. Halliday, Oral and systemic photoprotection, Photodermatol., Photoimmunol. Photomed., 2014, 30, 102–111.
M. Norval and G. M. Halliday, The consequences of UV-induced immunosuppression for human health, Photochem. Photobiol., 2011, 87, 965–977.
J. Breuer, N. Schwab, T. Schneider-Hohendorf, M. Marziniak, H. Mohan, U. Bhatia, C. C. Gross, B. E. Clausen, C. Weishaupt, T. A. Luger, S. G. Meuth, K. Loser and H. Wiendl, Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity, Ann. Neurol., 2014, 75, 739–758.
F. El Ghissassi, R. Baan, K. Straif, Y. Grosse, B. Secretan, V. Bouvard, L. Benbrahim-Tallaa, N. Guha, C. Freeman, L. Galichet and V. Cogliano, A review of human carcinogens–part D: radiation, Lancet Oncol., 2009, 10, 751–752.
G. M. Halliday, S. N. Byrne and D. L. Damian, Ultraviolet A Radiation: Its Role in Immunosuppression and Carcinogenesis, Semin. Cutaneous Med. Surg., 2011, 30, 214–221.
T. Y. Kim, M. L. Kripke and S. E. Ullrich, Immunosuppression by factors released from UV-irradiated epidermal cells: selective effects on the generation of contact and delayed hypersensitivity after exposure to UVA or UVB radiation, J. Invest. Dermatol., 1990, 94, 26–32.
A. A. El-Ghorr and M. Norval, The UV waveband dependencies in mice differ for the suppression of contact hypersensitivity, delayed-type hypersensitivity and cis-urocanic acid formation, J. Invest. Dermatol., 1999, 112, 757–762.
S. Rana, L. J. Rogers and G. M. Halliday, Systemic Low-Dose UVB Inhibits CD8 T Cells and Skin Inflammation by Alternative and Novel Mechanisms, Am. J. Pathol., 2011, 178, 2783–2791.
S. E. Ullrich, Mechanisms underlying UV-induced immune suppression, Mutat. Res., 2005, 571, 185–205.
S. E. Ullrich and S. N. Byrne, The immunologic revolution: photoimmunology, J. Invest. Dermatol., 2012, 132, 896–905.
M. P. Stapelberg, R. B. Williams, S. N. Byrne and G. M. Halliday, The Alternative Complement Pathway Seems to be a UVA Sensor that Leads to Systemic Immunosuppression, J. Invest. Dermatol., 2009, 129, 2694–2701.
M. Matsumoto, W. Fukuda, A. Circolo, J. Goellner, J. Strauss-Schoenberger, X. Wang, S. Fujita, T. Hidvegi, D. D. Chaplin and H. R. Colten, Abrogation of the alternative complement pathway by targeted deletion of murine factor B, Proc. Natl. Acad. Sci. U. S. A., 1997, 94, 8720–8725.
Q. Li, Y. X. Li, G. L. Stahl, J. M. Thurman, Y. He and H. H. Tong, Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice, Infect. Immun., 2011, 79, 2578–2585.
A. Javeri, J. G. Lyons, X. X. Huang and G. M. Halliday, Downregulation of Cockayne syndrome B protein reduces human 8-oxoguanine DNA glycosylase-1 expression and repair of UV radiation-induced 8-oxo-7,8-dihydro-2′-deoxyguanine, Cancer Sci., 2011, 102, 1651–1658.
C. A. Cole, R. E. Davies, P. D. Forbes, L. C. D’Aloisio, Comparison of action spectra for acute cutaneous responses to ultraviolet radiation: man and albino hairless mouse, Photochem. Photobiol., 1983, 37, 623–631.
P. A. J. Russo and G. M. Halliday, Inhibition of nitric oxide and reactive oxygen species production improves the ability of a sunscreen to protect from sunburn, immunosuppression and photocarcinogenesis, Br. J. Dermatol., 2006, 155, 408–415.
S. N. Byrne, A. Y. Limon-Flores and S. E. Ullrich, Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression, J. Immunol., 2008, 180, 4648–4655.
D. Ricklin, G. Hajishengallis, K. Yang and J. D. Lambris, Complement: a key system for immune surveillance and homeostasis, Nat. Immunol., 2010, 11, 785–797.
A. Rauterberg, E. G. Jung and E. W. Rauterberg, Complement deposits in epidermal cells after ultraviolet B exposure, Photodermatol., Photoimmunol. Photomed., 1993, 9, 135–143.
C. Hammerberg, S. K. Katiyar, M. C. Carroll and K. D. Cooper, Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance, J. Exp. Med., 1998, 187, 1133–1138.
D. L. Damian, Y. J. Matthews, T. A. Phan and G. M. Halliday, An action spectrum for ultraviolet radiation-induced immunosuppression in humans, Br. J. Dermatol., 2011, 164, 657–659.
D. L. Damian, R. S. Barnetson and G. M. Halliday, Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans, J. Invest. Dermatol., 1999, 112, 939–944.
T. S. C. Poon, R. S. C. Barnetson and G. M. Halliday, Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects, J. Invest. Dermatol., 2005, 125, 840–846.
S. N. Byrne, N. Spinks and G. M. Halliday, Ultraviolet A irradiation of C57BL/6 mice suppresses systemic contact hypersensitivity or enhances secondary immunity depending on dose, J. Invest. Dermatol., 2002, 119, 858–864.
M. C. Pickering, S. Fischer, M. R. Lewis, M. J. Walport, M. Botto and H. T. Cook, Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice, J. Invest. Dermatol., 2001, 117, 52–58.
P. H. Hart, M. A. Grimbaldeston, G. J. Swift, A. Jaksic, F. P. Noonan, J. J. Finlay-Jones, Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice, J. Exp. Med., 1998, 187, 2045–2053.
R. Chacon-Salinas, A. Y. Limon-Flores, A. D. Chavez-Blanco, A. Gonzalez-Estrada and S. E. Ullrich, Mast cell-derived IL-10 suppresses germinal center formation by affecting T follicular helper cell function, J. Immunol., 2011, 186, 25–31.
S. N. Sarchio, R. A. Scolyer, C. Beaugie, D. McDonald, F. Marsh-Wakefield, G. M. Halliday and S. N. Byrne, Pharmacologically Antagonizing the CXCR4-CXCL12 Chemokine Pathway with AMD3100 Inhibits Sunlight-Induced Skin Cancer, J. Invest. Dermatol., 2014, 134, 1091–1100.
P. Wolf, A. Gruber-Wackernagel, I. Bambach, U. Schmidbauer, G. Mayer, M. Absenger, E. Frohlich and S. N. Byrne, Photohardening of polymorphic light eruption patients decreases baseline epidermal Langerhans cell density while increasing mast cell numbers in the papillary dermis, Exp. Dermatol., 2014, 23, 428–430.
G. Nilsson, M. Johnell, C. H. Hammer, H. L. Tiffany, K. Nilsson, D. D. Metcalfe, A. Siegbahn and P. M. Murphy, C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway, J. Immunol., 1996, 157, 1693–1698.
M. A. Grimbaldeston, S. Nakae, J. Kalesnikoff, M. Tsai and S. J. Galli, Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B, Nat. Immunol., 2007, 8, 1095–1104.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Byrne, S.N., Hammond, K.J.L., Chan, C.YY. et al. The alternative complement component factor B regulates UV-induced oedema, systemic suppression of contact and delayed hypersensitivity, and mast cell infiltration into the skin. Photochem Photobiol Sci 14, 801–806 (2015). https://doi.org/10.1039/c4pp00399c
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c4pp00399c